Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Eicosapentaenoic Acid and Specialized Pro-Resolving Mediator for Depressive Symptoms in Long COVID: A Randomized Controlled Trial

NCT07711444 is registered in ClinicalTrials.gov with National Science and Technology Council, Taiwan as lead sponsor.

NCT NCT07711444
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07711444 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Eicosapentaenoic Acid and Specialized Pro-Resolving Mediator for Depressive Symptoms in Long COVID: A Randomized Controlled Trial
Lead sponsor
National Science and Technology Council, Taiwan
Phase
Not applicable
Overall status
Completed
Start date
June 1, 2024
Completion date
June 1, 2026
Enrollment
54 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

covid - 19, depression - major depressive disorder